Eleven Biotherapeutics (EBIO) Shares Tick Higher Upon Resumption

September 21, 2016 7:34 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Eleven Biotherapeutics (NASDAQ: EBIO) resumes trading. Shares are up nearly 8 percent in premarket action.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Trading Halts

Add Your Comment